Let's Do Insulin Next

Let's Do Insulin Next

by Dr Ben Miles

Humanities, Social Sciences & Thought Medicine & Health VFJBCoping withVFJB5Coping with
🎙 Dr Ben Miles 👥 2.5M 📅 May 9, 2021 ⏱ 10 min 👁 868 📄 opinion experte 🧭 2026-08-23
Available in: English (current) Français

Keywords

patentIP waiverinsulinvaccineincentives

Summary

The video discusses the proposal to waive intellectual property (IP) rights on insulin, following a tweet by AOC. The author, Dr Ben Miles, a PhD scientist and entrepreneur, provides his perspective based on his experience in developing an insulin therapy. He explains the purpose of patents as a system to incentivize innovation by granting temporary monopolies in exchange for public disclosure. He contrasts this with the case of Jonas Salk, who did not patent the polio vaccine, but notes that the development was publicly funded. The author then details the high costs of bringing a drug to market, using his own experience: after university research, his startup needed $1-1.5 billion for clinical trials and manufacturing. He argues that without patent protection, investors would not fund such risky ventures, as the first-to-market advantage would be lost. He also notes that even governments require guarantees, as seen in the US contract with Pfizer. The author concludes that while IP protection is necessary to maintain incentives, it should be balanced with price regulation to prevent excessive profits. He suggests tying drug prices to the minimum wage as a potential solution. The video is a reasoned opinion piece, not a scientific study, and aims to provoke thought and discussion.

205 words

Critical Evaluation

Value of the Information & Strength of the Argument

The video provides a valuable insider perspective on the pharmaceutical industry, particularly the role of patents in funding expensive drug development. The author’s personal experience with an insulin startup lends credibility to his arguments about the costs and risks involved. The argumentation is logically structured, moving from the general purpose of patents to the specific case of insulin and COVID-19 vaccines. He effectively uses the polio vaccine example and the Pfizer contract to illustrate his points. However, the argument is one-sided, focusing on the need for incentives without deeply exploring alternative models or the ethical implications of high drug prices. The proposed solution of price regulation is presented as a simple fix, but the complexities of implementation are not fully addressed.

130 words

Title / Content Match

The title accurately reflects the content, which discusses the proposal to apply an IP waiver to insulin, as suggested by AOC.

Quality & Reliability

7/10

The author, a PhD scientist and former CEO of a startup acquired for $800M, provides an informed opinion based on personal experience in the insulin development space. The video is a reasoned argument, but it is not a peer-reviewed analysis and relies on anecdotal evidence and simplified economic reasoning.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • Skillshare (affiliate link) — Mentioned in the video description as a resource for learning.

Concurring Sources

  • Patent law — Provides background on the purpose of patents as incentives for innovation.

Contribution & Novelties

The video offers a unique perspective from an entrepreneur who has navigated the drug development process, providing concrete numbers on the costs involved. It frames the IP waiver debate in terms of incentives and risk, arguing that removing patents could stifle innovation. The suggestion to tie drug prices to minimum wage is a novel, albeit provocative, idea.

Pour aller plus loin :

  • Patent law — Overview of patents and their economic rationale.
  • Jonas Salk — Background on the polio vaccine developer and his stance on patents.
  • Drug pricing — Discussion of pharmaceutical pricing strategies and controversies.

96 words

Radar Profile

The radar profile shows a balanced score across information quantity, quality, and reliability, with a lower technical level. This reflects the video's nature as an accessible opinion piece rather than a technical deep dive.

Reliability 7/10